Durham, NCNCT06076642Now EnrollingIRB Ready

Primary Immunodeficiency Diseases Clinical Trial in Durham, NC

Access cutting-edge primary immunodeficiency diseases treatment through this clinical trial at a research site in Durham. Study-provided care at no cost to qualified participants.

Sponsored by Takeda

Quick Self-Assessment

See if you qualify for this Durham location

Preparing your pre-screening questions...

Expert Care in Durham

Access primary immunodeficiency diseases specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related primary immunodeficiency diseases treatment provided free

Apply for This Durham Location

Check if you qualify for this primary immunodeficiency diseases clinical trial in Durham, NC

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Durham

    Convenient for NC residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Durham site if eligible
  4. 4Begin participation

About This Primary Immunodeficiency Diseases Study in Durham

The main aim of this study is to learn if TAK-881 is safe and well tolerated during long-term use in adults and children with PIDD who are eligible and completed study TAK-881-3001 (NCT05755035). The participants will receive the first dose of TAK-881 immunoglobulin (IgG) infusion at the same dosage as the last dose administered in study TAK-881-3001 (NCT05755035). After the first TAK-881 infusion in study TAK-881-3002, the dosing interval (can be adjusted by participant/caregiver) and/or the d

Sponsor: Takeda

Who Can Participate

Inclusion Criteria

Participants who meet ALL of the following criteria are eligible for this study:
Participant must have completed Study TAK-881-3001 (NCT05755035).
Participant/Participant's parent(s)/legal guardian(s) is/are willing and able to comply with the requirements of the protocol.
Participant/Participant's parent(s)/legal guardian(s) has/have provided informed consent/assent (if applicable), including providing consent for use of the investigational medical device, prior to the initiation of any study procedures.

Exclusion Criteria

Participant has a serious medical condition such that the participant's safety or medical care would be impacted by participation in this long-term follow-up study.
New medical condition that developed during participation in Study TAK-881-3001 (NCT05755035), that, in the judgment of the investigator, could increase risk to the participant or interfere with the evaluation of TAK-881 and/or conduct of the study.
Participant has part

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Durham?

Yes, this clinical trial (NCT06076642) has an active research site in Durham, NC that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Primary Immunodeficiency Diseases Treatment Options in Durham, NC

If you're searching for primary immunodeficiency diseases treatment options in Durham, NC, this clinical trial (NCT06076642) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Durham research site is actively enrolling participants for this clinical trial. You'll receive care from experienced primary immunodeficiency diseases specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all primary immunodeficiency diseases clinical trials near you to find additional studies recruiting in your area.

More Multiple Myeloma Trials in Durham, NC

See all multiple myeloma clinical trials recruiting in Durham — not just this study.

Browse Multiple Myeloma Trials in Durham →

Browse More Trials by Condition

Multiple Myeloma TrialsAnkylosing Spondylitis TrialsInterstitial Cystitis TrialsAll Conditions →

Ready to Join in Durham?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Durham, NC